- US12616737utility2026Liquid Formulations of Amylin Analogues0 cites
- US12576025utility2026Pharmaceutical Parenteral Composition of Dual GLP1/2 Agonist0 cites
- US12473339utility2025Acylated Glucagon Analogues0 cites
- US12297251utility2025Injection Pen for Subcutaneous Administration of a Peptide0 cites
- US12083164utility2024Amylin Analogues0 cites
- US12077611utility2024Cyclic Peptides Multimers Targeting Α4β7 Integrin0 cites
- US11957761utility2024Compounds Having Α4β7 Integrin Inhibition Activity0 cites
- US11884713utility2024Acylated Glucagon Analogues0 cites
- US11814417utility2023GIP Agonist Compounds and Methods0 cites
- US11795204utility2023Glucagon Analogues0 cites
- US11780893utility2023Kv1.3 Blockers0 cites
- US11713338utility2023Cyclic Peptides Multimers Targeting Α-4-β-7 Integrin0 cites